Muhdo partner with King’s College London in an advanced research project around epigenetics, AI and informatics.
Longevity.Technology: Epigenetic tests – identifying and mitigating the health challenges and predispositions of the individual – is big news. Last year we covered Muhdo‘s collaboration with My PT Hub to bring the benefits of DNA and epigenetic testing to the world of personal training and this new collaboration will focus on how AI can help people to better understand the value of health and lifestyle data, for both end consumers and those researching healthy longevity.
The gap between life and health expectancy is growing larger every year. Our health and lifestyle needs are also changing, and more research is required to reduce the risk of preventable aging-related diseases to improve physical and mental wellbeing throughout the life course.
We might be living longer, but unfortunately not as healthily as we should; numbers of multiple long-term conditions like asthma, diabetes, obesity and heart disease are on the rise, and patients with multiple long term conditions are becoming the norm rather than the exception. However, it is estimated that around 75% of health and life expectancy after the age of 40 is modifiable.
Muhdo is pioneering epigenetics testing in the workplace and community, with the goal of helping people understand our biological age and better predicting their future health, bridging the gap between consumer wellness and technology. This will allow people to be more proactive in helping to manage their health and wellbeing through lifestyle changes.
Together with ARK-affiliated academics and healthcare professionals, as well as industry partners, Muhdo aims to develop the next generation of consumer epigenetics testing integrated with other biomarkers of lifestyle and environmental data through AI and advanced data analytics. In particular, Svitlana Surodina, ARK’s new Entrepreneur in Residence and researcher in the Department of Informatics at King’s, will be developing novel technologies for integrating with Muhdo’s platform.
Siow’s research focuses on nutrigenomics for healthy longevity and the mechanisms of aging. He has published extensively in leading biomedical journals and is the UK Lead for the International Society on Ageing and Disease. He is an Associate Editor of Frontiers in Genetics and Frontiers in Nutrition and a member of the Advisory Board of the UK All Party Parliamentary Group for Longevity and The Lancet Healthy Longevity.
Nathan Berkley, CEO of Muhdo, said: “We at Muhdo are very excited to be partnering with one of the most respected universities in this field and carry out this cutting-edge research looking at health and wellbeing data and the value it can provide to everyone in terms of looking after their own wellbeing.
“DNA and epigenetics have the capability to help everyone at every stage of life to reach their full health potential. We believe this is a true milestone in the global application of epigenetics .”
Richard Siow, Director of ARK, commented: “We’re always searching for novel ways to push the boundaries of our research in applying the scientific breakthroughs to the real-world problems and partnering with market leaders to deliver a major impact on people’s lives and society at large. We are delighted to start this cooperation with Muhdo which will apply the data science and AI innovations to improve global health and longevity .”